Zinc-integrated PLGA/chitosan nanofiber mesh: a platform for wound healing applications
Abstract
Non-healing wounds present significant challenges to patients and healthcare systems, often causing infections and chronic pain due to impaired self-regeneration. Zinc (Zn) shows promise in biomedical applications, particularly wound healing, as its degradation releases Zn2+ ions that enhance cell proliferation, angiogenesis, and antimicrobial activity. These properties make Zn ideal for bioresorbable wound dressings, scaffolds, and tissue repair coatings. This study aimed to incorporate metallic Zn particles into electrospun nanofiber meshes of poly(d,l-lactic-co-glycolic acid) (PLGA) and PLGA/chitosan (PLGA-CH) and evaluate their wound healing potential. We electrospun polymer-Zn nanoparticle mixtures to fabricate composite fibrous meshes. We assessed Zn's impact on scaffolds' physical, chemical, and biological properties, including fiber morphology, chemical composition, mechanical strength, and Zn2+ release. Results showed Zn influences PLGA's physical properties without altering chemical composition. Zn-containing meshes released Zn2+ ions in a dose-dependent manner. Biological evaluations using 3T3 fibroblasts over three days revealed fiber composition-dependent cytotoxicity, with certain compositions supporting cell proliferation, suggesting potential for tissue remodelling. Given PLGA and chitosan's biocompatibility and biodegradability, incorporating Zn into composite nanofiber meshes presents a promising approach for wound healing and tissue engineering…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.